Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000579185 | SCV000680798 | uncertain significance | not provided | 2017-12-01 | criteria provided, single submitter | clinical testing | The c.237 C>T variant has not been published as a pathogenic variant, nor has it been reported as a benign variant to our knowledge. The c.237 C>T variant is observed in 52/24,036 (0.2%) alleles from individuals of African background, in the ExAC dataset (Lek et al., 2016). Although in silico splice prediction models do not predict that c.237 C>T affects splicing, in the absence of RNA/functional studies, the actual effect of this sequence change in this individual is unknown. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic variant or a rare benign variant. |
Labcorp Genetics |
RCV001080728 | SCV001022183 | likely benign | Isovaleryl-CoA dehydrogenase deficiency | 2024-11-11 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001080728 | SCV001456703 | likely benign | Isovaleryl-CoA dehydrogenase deficiency | 2020-04-16 | no assertion criteria provided | clinical testing |